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ABSTRACT
Objectives: To examine the effects of birth weight
and childhood growth on childhood wheezing
disorders. We hypothesised that low birth weight and
fast growth during early age would increase the risk of
wheezing disorders.
Setting: Observational secondary analysis of data from
the Born in Bradford cohort.
Participants: All children who were born at the
Bradford Royal Infirmary hospital between March 2007
and December 2010 were eligible for the study. A total
of 13 734 and 1598 children participated in the
analyses of the effects of birth weight and growth on
wheezing disorders, respectively.
Primary and secondary outcome measures:
Wheezing disorders diagnosis (diagnosed as asthma
or had wheezing symptom) during the ages of 0–
7 years were the primary outcome measures. Diagnosis
of asthma and occurrence of wheezing during the
same period were secondary outcome measures. Birth
weight was classified as normal (2.5–4.0 kg), low
(<2.5 kg) and high (>4.0 kg). Growth mixture models
were used to drive growth pattern outcomes which
were classified as ‘normal’, ‘fast’ and ‘slow’ growth
based on their velocities between birth and 36 months.
Results: The adjusted relative risks (RRs) of wheezing
disorders diagnosis for the low and high birthweight
children were 1.29 (95% CI 1.12 to 1.50; p=0.001) and
0.91 (95% CI 0.79 to 1.04; p=0.17), respectively. The
adjusted RRs of wheezing disorders diagnosis were
1.30 (95% CI 0.56 to 3.06; p=0.54) and 0.60 (95% CI
0.16 to 2.18; p=0.44), respectively, for the ‘fast’ and
‘slow’ growth as compared with the ‘normal’ growth.
Conclusions: Low birth weight is associated with an
increased risk of wheezing disorders; however, there is a
weak evidence that suggests high birthweight children
have a reduced risk in this birth cohort. Low birth
weight coupled with a slower growth until 3 months and
a sharp growth between 3 and 12 months has an
increased risk of wheezing disorders diagnosis.
INTRODUCTION
Asthma is deﬁned as a chronic disease of the
passage of airways, characterised by smooth
muscle contraction, accumulation of mucous
and debris in the lumen, vascular congestion
and airway wall oedema which leads to breath-
lessness and wheezing.1 Although it is claimed
to be the most common childhood disease,2
there is, however, a lack of consistency in its
diagnosis in clinical practice.3 This is due to
the difﬁculty in diagnosing asthma in chil-
dren, especially those of preschool age, in
whom wheezing, which is the main symptom
for asthma, can be caused by other illnesses.4
In addition, although there are various
asthma conﬁrmatory tests available,5 young
children can be less cooperative in participat-
ing in such tests leading to an underdiagnosis
of true asthma cases. Therefore, the word
‘asthma’ may not be an adequate term for
what can be described as a spectrum of
respiratory problems. As a result, some
researchers have tended to use more inclusive
terms such as ‘wheezing disorders’.6–9
The effect of birth weight on wheezing dis-
orders has been studied extensively with
Strengths and limitations of this study
▪ A large sample, contemporary birth cohort data
were used.
▪ Direct Acyclic Graphs (DAGs) were used to min-
imise potential bias due to confounding.
▪ Multiple imputation by chained equations was
used to minimise bias due to missing data.
▪ Age-specific and sex-specific standardised
scores and growth percentiles were used to illus-
trate the growth of cohort children in reference
to standard growth charts.
▪ Selection of participants was not random.
▪ Number of individuals in some of the growth
classes was small, so the risk estimates were not
robust.
▪ There was a substantial missing growth data at
some follow-up periods, although missing data
estimation models were used to minimise bias.
▪ Information on potential confounding (ie, family
asthma and breast feeding) was missing.
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more than 40 observational epidemiological studies
carried out to date. In our recent meta-analysis and sys-
tematic review of these studies, we reported that low birth-
weight children (<2.5 kg) have a 60% (OR 1.60; 95% CI
1.39 to 1.85) and 37% (OR=1.37; 95% CI 1.05 to 1.79)
higher risk of wheezing disorders when compared with
≥2.5 and 2.5–4.0 kg birthweight children, respectively.10
We also found a modest increased risk in high birth-
weight children (>4 kg) when compared with normal
birthweight (2.5–4.0 kg) children (OR 1.02; 95% CI 0.99
to 1.04). However, we acknowledged there was substantial
heterogeneity among the low birthweight risk estimates
which was not accounted for by study characteristics.
The effect of early childhood growth on wheezing dis-
orders has not been widely studied. Results from a
handful of previous studies are inconsistent with some
suggesting fast growth predisposes to wheezing disor-
ders11–20 and others reporting reduced risk of wheezing
disorders.19 21–23 In addition to that, all of these studies,
with the exception of one,18 assumed homogeneous
growth among children, either used statistical techni-
ques that can now be improved on or a non-standard
growth data analysis that makes comparison and replica-
tion of results very difﬁcult. For example, three11 16 20
used data-driven standardised scores (SDS),
three12 19 22 23 used country-speciﬁc SDS and another
one14 used non-standardised weight measurements.
The aim of the study was twofold: (1) further investiga-
tion of the effects of birth weight on wheezing disorders;
and (2) investigation of the effects of early growth on
wheezing disorders using a birth cohort data.
METHODS
Study participants
The Born in Bradford (BiB) study is a prospective, mainly
biethnic, cohort that examines the impact of environmen-
tal, genetic and social factors on health of the population
of Bradford.24 The methods of recruitment are explained
in detail elsewhere.24 25 In brief: recruitment of partici-
pants started in March 2007 and ended in December
2010; a total of 13 776 pregnant mothers were recruited
that resulted in 13 857 births. Out of the total births, 123
died before the age of 1 week which resulted in a total of
13 734 children to be included in the birthweight and
childhood wheezing disorders analyses.
At the same time, a subcohort (BiB1000) of 1735
mothers and 1763 babies were also recruited for
follow-up examinations. After excluding multiple births,
preterm births and death before the age of 1 week, a
total of 1598 children were included in growth pattern
and wheezing disorder analyses.
Data collection
We have used ﬁve data sources: (1) hospital maternity
records for information on birth weight, gestational age,
gender of a child and number of live births; (2) BiB1000
cohort records for weight at 6, 12, 18, 24 and 36 months
of age, that is, during the ﬁrst, second, third, fourth and
ﬁfth visit after birth, respectively; (3) community health
records for weight at 1 and 3 months of age; (4) base-
line questionnaire data collected from the mothers on
recruitment about their ethnicity, smoking and socio-
economic status (SES); and (5) linked primary care data
about outcome variables (wheezing disorder diagnosis
terms and treatment) recorded as Read Codes (http://
systems.hscic.gov.uk/data/uktc/readcodes).
Case definition and ascertainment
We drew up four disease deﬁnitions based on diagnostic
codes and prescribed medication details entered by
general practitioners onto the primary care database.
1. Asthma diagnosis: presence of asthma codes in the
record;
2. Wheezing symptoms: presence of wheezing diagnosis
codes in the record;
3. Wheezing disorder based on diagnosis (wheezing dis-
order diagnosis): presence of asthma or wheezing
diagnosis codes in the record;
4. Wheezing disorder based on treatment (wheezing
disorder treatment), existence of at least two drug
prescriptions indicated for the treatment of asthma a
minimum of 1 week and maximum of 12 months
apart.
Drug and disease terms and codes used to conﬁrm
occurrences of wheezing disorders any time between 0
and 7 years of age are listed in online supplementary
tables S1 and S2.
Variables for analysis
Primary variables
Where regression modelling was carried out, exposure
variables were birth weight and growth; outcome vari-
ables were wheezing disorders (ie, asthma diagnosis,
wheezing symptoms, wheezing disorders diagnosis and
wheezing disorders treatment).
Two types of growth variables were used: age-based
and visits-based. For the age-based growth, age of a child
when the measurement of weight occurred was used as a
time score. The data were collected through maternity
records, BiB1000 questionnaire and the community
health records, so the time points: 0, 1, 3, 6, 12, 18, 24
and 36 months were used as time scores. In the visits-
based, however, only maternity records and the BiB1000
questionnaire data were considered. Therefore, 0, 1, 2,
3, 4 and 5 were used as times scores. Note that 0 stands
for time when birth weight was measured (ie, birth),
and 1, 2, 3, 4 and 5 represent 6, 12, 18, 24 and
36 months of BiB1000 questionnaires, respectively.
The aim of using the age-based and visits-based time
scores was to explore the effects of growth in terms of
latent growth factors (ie, intercept and slope) and
weight status (ie, underweight, normal, overweight or
obese based on the weight percentiles) at every visit,
respectively. In the age-based approach, the age of the
children at each time point needed to be identical or
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weight values were constrained to be missing if the
recorded weight measurement did not reﬂect the time
points. In the visits-based approach, however, the age of
the children at each time point did not need to be iden-
tical and no constraint was imposed. The main differ-
ence between these two approaches was that in the
age-based, group classiﬁcation was based on how fast or
slow the children grow as their age was identical or con-
strained to be identical. On the visits-based, however,
although the group classiﬁcation was similar to the age-
based, the outputted intercept and slope were artiﬁcial
and were not used to characterise how fast or slow the
children grew between two times points as the age of
children was not constrained to be identical. In addition,
the age-based data had more missing value than the
visits-based due to the constraint of age to be identical
during the respective time points.
Confounding variables
Selection of variables was carried out based on the cri-
teria that confounding variable must have an effect on
the exposure and outcome variables, and should not be
on the causal pathway.26–28 In order to minimise bias
due to confounding and overadjustment, Direct Acyclic
Graphs (DAGs) were used27 29 and models were tested
using DAGitty software.28 Drawing a relationship
between variables of interest (ie, confounding and main
variables) was guided by epidemiological, biological and
clinical knowledge. Online supplementary ﬁgures S1
and S2 illustrate the schematic view of adjustment and
output for the list of ‘minimally sufﬁcient’ confounding
sets using DAGitty software.
In assessing the effect of birth weight on wheezing dis-
orders, ethnicity, family asthma, gender, gestational age,
maternal smoking, number of live births, parity and SES
were selected as ‘minimally sufﬁcient’ set of confound-
ing variables. In assessing the effect of childhood growth
on wheezing disorders, birth weight, ethnicity, family
asthma, breast feeding, gender, maternal smoking, parity
and SES were selected as ‘minimally sufﬁcient’ set of
confounding variables.
However, note that selection among sets of confound-
ing variables was carried out retrospectively. Hence,
availability of information on variables was also a factor
during the selection process. As such, although the
selected sets were better than the other candidate sets,
no data were available for the variables ‘family asthma’
and ‘breast feeding’.
Missing data estimation variables
Where imputations were carried out, missing data were
estimated under Missing Data at Random (MAR)
assumption that the missingness on outcome variables
does not depend on the outcome variables themselves
but can be explained by (or related to) other variables
included in the imputation models (also known as auxil-
iary variables).30 The auxiliary variables included in the
imputation process were: exposure variables,
confounding variables and variables that can be related
to the missingness. The ﬁrst two types of variables were
those included in the analysis models, whereas the third
types of variables (maternal hypertension and diabetes)
were included only in the imputation models.
A brief check on the variables before carrying out
imputations showed that birth weight, gestational age
and outcome variables (ie, asthma diagnosis, wheezing
symptoms, wheezing disorder treatment and wheezing
disorder diagnosis) were completely observed. To
further explore if imputations were necessary or beneﬁ-
cial, dummy variables (ie, yes or no) were created as
missing data indicator for each covariate with missing
observations. When the missingness indicator variables
and outcome variables were tested for correlations, the
results consistently showed that there were no signiﬁcant
associations which also indicate that complete cases ana-
lysis could produce unbiased, albeit less precise, param-
eter estimates.31 However, there were consistent
signiﬁcant associations between the missing indicator
variables and other confounding variables which also
suggest that imputations with inclusion of these covari-
ates may improve the precision of the parameter
estimates.30 31
Statistical analysis and software
Birth weight was classiﬁed according to the Centre of
Diseases Prevention and Control (CDC)32 and WHO
methods33 where <2.5 kg=low, 2.5–4.0 kg=normal and
>4.0 kg=high. Age-speciﬁc and sex-speciﬁc SDS of weight
were derived according to WHO growth standards34 in
LMSgrowth Microsoft excel add-in software.35 The WHO
growth standards population that we used to derive the
SDS was made up of singleton term births. Hence, mul-
tiple and preterm births were excluded from the growth
patterns and wheezing disorders analyses.
In identifying the best ﬁtting growth patterns, growth
mixture models (GMMs) were ﬁtted,36 37 and in select-
ing the optimal number of classes and best growth
model, we used model classiﬁcation quality and model ﬁt
statistics. In addition, interpretability was also considered
where we rejected models that consist of a class with
≤1% of the total population. When comparing growth
patterns of children in our GMMs, we used WHO growth
standards charts34 as a point of reference. In converting
weight SDS into percentiles, we used a one-sided normal
standard distribution. For example, weight SDS of −1.64,
0, 1.04 and 1.64 are equivalent to the 5th, 50th, 85th and
95th centiles, respectively.
Missing data on covariates were estimated using
Multiple Imputations by Chained Equation (MICE)
models under MAR assumptions.38 39 In deciding how
many data sets to be imputed, we took the number of
imputations (n) to be greater than the percentage or
fraction of incomplete cases.38 40 Missing growth data
were estimated using a Full Information Maximum
Likelihood (FIML) method in which parameters are
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estimated using all available observations in the data set,
under MAR assumption.41 42
GMM was carried out in Mplus V.7.11, and covariates’
missing data estimation and regression modelling were
carried out in Stata V.12. Five per cent signiﬁcance levels
and 95% CIs were adopted throughout.
RESULTS
Birth weight and wheezing disorders
The cohort was made up of 13 734 children that yielded
74 940 person years of follow-up. In total, 37.3% and
32.8% were Pakistani and white British origin, respect-
ively; 12.6% were minority and 17.3% with missing ethni-
city data. In total, 50.4% and 47.3% were male and
female, respectively, and 2.3% of children had missing
information on sex. In total, 82.6%, 9.1% and 8.3% of
the cohort were ‘normal’, ‘high’ and ‘low’ birthweight
children, respectively (table 1). Out of 13 734 children,
6.1% were diagnosed as asthmatic, 14.5% had wheezing
symptoms, 17.1% were either diagnosed for asthma or
had wheezing symptoms, and 22.1% children were
treated with asthma drugs based on primary care data
available up to November 2014 (table 1).
Low birth weight
Low birth weight was associated with all four disease
deﬁnitions. The adjusted relative risks (RRs) for
‘asthma’ diagnosis, ‘wheezing’ symptoms, ‘wheezing dis-
order’ diagnosis and ‘wheezing disorder’ treatment were
1.53 (95% CI 1.20 to 1.96), 1.29 (95% CI 1.10 to 1.52),
1.29 (95% CI 1.12 to 1.50) and 1.25 (95% CI 1.10 to
1.42), respectively (table 2). The respective unadjusted
RRs were 1.55 (95% CI 1.27 to 1.89), 1.29 (95% CI 1.13
to 1.46), 1.28 (95% CI 1.14 to 1.45) and 1.27 (95% CI
1.15 to 1.40).
High birth weight
There was a consistent but weak evidence for a reduc-
tion of wheezing disorders risk for those children who
were classiﬁed as being of high birth weight. The
adjusted RRs for ‘asthma’ diagnosis, ‘wheezing’ symp-
toms, ‘wheezing disorder’ diagnosis and ‘wheezing dis-
order’ treatment were 0.95 (95% CI 0.74 to 1.22), 0.90
Table 1 Characteristics of 13 734 children with complete data on wheezing disorders and covariates
Asthma diagnosis Wheezing symptoms
Wheezing disorder
diagnosis
Wheezing disorder
treatment
Yes/no Yes (%) Yes/no Yes (%) Yes/no Yes (%) Yes/no Yes (%)
Birth weight (kg)
Normal (2.5–4.0) 668/10 673 5.9 1622/9719 14.3 1907/9434 16.8 2444/8897 21.6
Low (<2.5) 104/1035 9.1 209/930 18.3 246/893 21.6 311/828 27.3
High (>4.0) 69/1185 5.5 163/1091 13.0 194/1060 15.5 280/974 22.3
Ethnicity
White British 217/4284 4.8 586/3915 13.1 706/3795 15.7 1074/3427 23.9
Pakistani 382/4735 7.5 857/4260 16.7 985/4132 19.2 1150/3967 22.5
Others 86/1647 5.0 207/1526 11.9 243/1490 14.0 308/1425 17.8
Gender
Male 502/6415 7.3 1220/5697 17.6 1416/5501 20.5 1775/5142 25.7
Female 318/6172 4.9 742/5748 11.4 890/5600 13.7 1190/5300 18.3
Gestational age
Term 769/12 100 6.0 1841/11 028 14.3 2166/10 703 16.8 2792/10 077 21.7
Preterm 72/793 8.3 153/712 17.7 181/684 20.9 243/622 28.1
Number of births
Singleton 803/12 281 6.1 1923/11 161 14.7 2262/10 822 17.3 2911/10 173 22.2
Twins 17/297 5.4 38/276 12.1 43/271 13.7 52/262 16.6
Triplets 0/9 0 1/8 11.1 1/8 11.1 2/7 22.2
Maternal smoking
No 520/7371 6.6 1162/6729 14.7 1359/6532 17.2 1710/6181 21.7
Yes 167/3295 4.8 490/2972 14.2 578/2884 16.7 823/2639 23.8
Parity
Primiparous 292/4823 5.7 686/4429 13.4 821/4294 16.1 1128/3987 22.1
Multiparous 489/7311 6.3 1210/6590 15.5 1401/6399 18.0 1728/6072 22.2
IMD 2010 quintile score
1 487/7048 6.5 1182/6353 15.7 1372/6163 18.2 1721/5814 22.8
2 115/1939 5.6 253/1801 12.3 304/1750 14.8 435/1619 21.2
3 59/1196 4.7 148/1107 11.8 177/1078 14.1 247/1008 19.7
4 18/317 5.4 41/294 12.2 53/282 15.8 84/251 25.1
5 8/184 4.2 30/162 15.6 33/159 17.2 49/143 25.5
IMD, index of multiple deprivation with 1 and 5 indicating the least deprived and most deprived scores, respectively.
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(95% CI 0.77 to 1.04), 0.91 (95% CI 0.79 to 1.04) and
0.99 (95% CI 0.89 to1.11), respectively (table 2). The
respective unadjusted RRs of high birth weight for
‘asthma’ diagnosis, ‘wheezing’ symptoms, ‘wheezing dis-
order’ diagnosis and ‘wheezing disorder’ treatment were
0.93 (95% CI 0.73 to 1.19), 0.91 (95% CI 0.78 to 1.06),
0.92 (95% CI 0.80 to 1.05) and 1.04 (95% CI 0.93 to
1.16).
Growth and wheezing disorders
The BiB1000 follow-up cohort consisted of 1598 chil-
dren that contributed a total of 8683 person years of
follow-up. The total number of children who had
‘asthma’ diagnosis, ‘wheezing’ symptoms, ‘wheezing dis-
orders’ diagnosis and ‘wheezing disorders’ treatment
were 113 (7.1%), 252 (15.8%), 300 (18.8%) and 369
(23.1%), respectively, slightly higher than the whole BiB
cohort. Fewer than 2% and 10% of the BiB1000 chil-
dren were diagnosed with or treated for wheezing disor-
ders during the ﬁrst 3 months and the ﬁrst 6 months,
respectively (see online supplementary table S3).
Age-based weight patterns
According to the optimal number of class determination
results, a four class model was best (see online supple-
mentary table S4). However, a three class model was pre-
ferred on an interpretability basis (table 3 and online
supplementary ﬁgure S3A). Class 1 (95.8%) was com-
posed of children whose mean birth weight was at the
46th centile and were just over the 60th centile at the
age of 1 year and stayed around 60th centile afterwards
according to WHO growth standards.34 Class 2 (2.2%)
was composed of children whose mean weight at birth
was on the 28th centile then increased to the 96th
centile at 1 year of age and persisted to be overweight
until the age of 3. Class 3 (2.0%) were a group of chil-
dren whose mean birth weight was on the 29th centile,
who subsequently showed very slow growth, their mean
weight reaching the 3rd centile at 1 year of age, followed
by moderate acceleration to reach the 56th centile by
the age of 3. Class 1, class 2 and class 3 could be charac-
terised as ‘normal’, ‘fast’ and ‘slow’ growth groups,
respectively. Online supplementary table S5 gives esti-
mated means of the growth model parameters.
The adjusted RRs for ‘asthma’ diagnosis, ‘wheezing’
symptoms, ‘wheezing disorder’ diagnosis and ‘wheezing
disorders’ treatment for fast growth group were 0.81
(95% CI 0.12 to 5.46), 1.59 (95% CI 0.67 to 3.71), 1.30
(95% CI 0.56 to 3.06) and 0.77 (95% CI 0.20 to 2.51),
respectively, when compared with the ‘normal’ growth
group (table 4). The adjusted RRs of the ‘slow’ as com-
pared with the ‘normal’ growth group for ‘wheezing’
symptoms, ‘wheezing disorder’ diagnosis and ‘wheezing
disorders’ treatment were 0.72 (95% CI 0.20 to 2.62),
Table 2 Adjusted relative risks and 95% CIs of covariates using 40 imputed data sets
Asthma
diagnosis
Wheezing
symptoms
Wheezing disorder
diagnosis
Wheezing disorder
treatment
Birth weight (kg)
Normal (2.5–4.0) 1 1 1 1
High (>4.0) 0.95 (0.75 to 1.22) 0.90 (0.77 to 1.04) 0.91 (0.79 to 1.04) 0.99 (0.89 to1.11)
Low (<2.5) 1.53 (1.20 to 1.96) 1.29 (1.10 to 1.52) 1.29 (1.12 to 1.50) 1.25 (1.10 to 1.42)
Ethnicity
White British 1 1 1 1
Pakistani 1.36 (1.11 to 1.66) 1.26 (1.12 to 1.42) 1.21(1.08 to 1.35) 0.95 (0.87 to 1.05)
Others 0.96 (0.74 to 1.25) 0.93 (0.79 to 1.08) 0.90 (0.78 to 1.04) 0.76 (0.67 to 0.85)
Gender
Male 1 1 1 1
Female 0.67 (0.58 to 0.76) 0.64 (0.59 to 0.70) 0.66 (0.61 to 0.72) 0.71 (0.67 to 0.76)
Gestational age
Term 1 1 1 1
Preterm 1.11 (0.83 to 1.48) 1.08 (0.90 to 1.30) 1.09 (0.92 to 1.29) 1.16 (1.01 to 1.34)
Number of births
Singleton 1 1 1 1
Twins 0.68 (0.42 to 1.10) 0.71 (0.52 to 0.97) 0.68 (0.51 to 0.90) 0.63 (0.49 to 0.81)
Triplets – 0.57 (0.09 to 3.60) 0.48 (0.08 to 3.03) 0.75 (0.22 to 2.56)
Maternal smoking
No 1 1 1 1
Yes 0.86 (0.70 to 1.05) 1.10 (0.98 to 1.24) 1.07 (0.97 to 1.19) 1.05 (0.97 to 1.15)
Parity
Primiparous 1 1 1 1
Multiparous 1.04 (0.91 to 1.20) 1.14 (1.04 to 1.24) 1.10 (1.02 to 1.19) 1.02 (0.95 to 1.08)
IMD 2010 quintile score 0.96 (0.88 to 1.05) 0.95 (0.90 to 1.00) 0.95 (0.91 to 1.00) 0.97 (0.93 to 1.00)
Model adjusted for ethnicity, gender, gestational age, number of births, maternal smoking, parity and IMD score.
IMD, index of multiple deprivation.
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0.60 (95% CI 0.16 to 1.95) and 0.81 (95% CI 0.29 to
2.25), respectively. The respective unadjusted RRs for
both growth groups remained similar (table 4).
Visits-based growth patterns
The age ranges of the children during their
ﬁrst, second, third, fourth and ﬁfth visits after birth
were 4.9–9.4, 10.7–18.3, 15.2–22.8, 23.4–28.5 and
35.4–40.6 months, respectively. Although the determin-
ation of the optimal number of classes favoured a model
with four classes, the two class model was selected on a
model interpretability basis (see online supplementary
table S4). Class 1 (92.7%) comprised those children
who were around the 46th centile at birth and 52nd
centile during the ﬁrst visit after birth and remained
around the 60th centile during the next four visits
according to the WHO growth standards chart34; class 2
(7.3%) comprised children who were, on average, at the
29th centile at birth and 57th centile during the ﬁrst
visit after birth then consistently accelerated to reach the
95th centile during the last visit (see online supplemen-
tary ﬁgure S3B and table 3). Class 1 and class 2 could be
characterised as ‘inconsistent’ and ‘consistent’ growth
groups, respectively.
The adjusted RRs for ‘asthma’ diagnosis, ‘wheezing’
symptoms, ‘wheezing disorder’ diagnosis and ‘wheezing
disorders’ treatment for the ‘inconsistent’ growth group
were 1.47 (95% CI 0.71 to 3.01), 1.13 (95% CI 0.66 to
1.95), 1.38 (95% CI 0.90 to 2.12) and 1.17 (95% CI 0.76
to 1.81), respectively, when compared with the ‘consist-
ent’ growth group. The respective unadjusted RRs
remained similar (table 5).
Complete cases versus imputed data set results
The complete cases analysis for birth weight and wheez-
ing disorders retained 10 623 out of 13 734 children.
The complete case analyses for weight growth patterns
based on age and visits retained 1572 of the 1598 chil-
dren. The results of complete case analyses were very
close to the imputed data analyses as expected given
that all the outcome variables were completely observed
and the missing indicator variables for the incomplete
covariates did not have strong relationship with the
outcome variables (see online supplementary tables S6
and S7).
DISCUSSION
In this prospective cohort study, we found that low birth
weight was strongly associated with wheezing disorders
and there was consistent, albeit weak, evidence that high
birth weight was associated with reduced risk of wheez-
ing disorders during the preschool period. Our ﬁndings
for the effects of low birth weight on wheezing disorder
diagnosis and treatment are in line with the ﬁndings of
our recent meta-analysis and systematic review, showing a
37% increase in wheezing disorders risk for low birth
weight (OR=1.37; 95% CI 1.05 to 1.79) compared with
normal birth weight,10 although the results here are
slightly attenuated due to our use of RR as a measure of
association. However, our ﬁnding of the effect of high
birth weight on wheezing disorders is slightly different
to that of the reported OR in the meta-analysis
(OR=1.02; 95% CI 0.99 to 1.04) with both wheezing dis-
orders diagnosis and treatment showing that there was a
non-signiﬁcant reduction of risk.
Analysis of our age-based weight growth patterns have
shown inconsistent results for the group classiﬁed as
‘fast’ growth group. While there was a weak evidence for
an increased risk of wheezing disorders according to
diagnosis, there was a weak evidence for a reduced risk
of wheezing disorders treatment (table 5). However, the
Table 3 Estimated mean and percentiles of 1598 children by growth classes
Growth classes
Class 1 Class 2 Class 3
Age-based weight SDS
Birth 46th (–0.11 SDS) 28th (–0.59 SDS) 29th (–0.56 SDS)
1 month 43rd (–0.18 SDS) 19th (–0.89 SDS) 23rd (–0.75 SDS)
3 months 38th (–0.31 SDS) 7th (–1.48 SDS) 13th (–1.13 SDS)
6 months 45th (–0.12 SDS) 34th (–0.40 SDS) 8th (–1.39 SDS)
12 months 61st (0.27 SDS) 96th (1.75 SDS) 3rd (–1.91 SDS)
18 months 60th (0.25 SDS) 94th (1.57 SDS) 8th (–1.40 SDS)
24 months 59th (0.23 SDS) 92nd (1.39 SDS) 19th (–0.88 SDS)
36 months 58th (0.20 SDS) 85th (1.02 SDS) 56th (0.14 SDS)
Visits-based weight SDS
Birth 47th (–0.08 SDS) 40th (–0.26 SDS) –
1st visit 53rd (0.04 SDS) 56th (0.16 SDS) –
2nd visit 55th (0.13 SDS) 71rd (0.54 SDS) –
3rd visit 57th (0.18 SDS) 81st (0.89 SDS) –
4th visit 57th (0.19 SDS) 88th (1.20 SDS) –
5th visit 53rd (0.09 SDS) 96th (1.70 SDS) –
SDS, standardised scores.
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results showed that the ‘slow’ growth group did have a
reduced risk for both wheezing disorders diagnosis and
treatment, albeit weak evidence, when compared with
the ‘normal’ growth group (table 5). Furthermore, in
our attempt to further analyse the effects of visits-based
weight SDS on wheezing disorders, there was a weak evi-
dence for an increase risk of wheezing disorders diagno-
sis and treatment for the group of children who grew
‘inconsistently’ and were seen to be obese by the last
visit.
Table 4 Characteristics of 1598 children with complete data on wheezing disorders and covariates
Asthma diagnosis
Wheezing
symptoms
Wheezing disorder
diagnosis
Wheezing disorder
treatment
Yes/no Yes (%) Yes/no Yes (%) Yes/no Yes (%) Yes/no Yes (%)
Birth weight (kg)
Normal (2.5–4.0) 101/1314 7.1 221/1194 15.6 264/1151 18.7 321/1094 22.7
Low (<2.5) 6/64 8.6 14/56 20.0 16/54 22.9 20/50 28.6
High (>4.0) 6/107 5.3 17/96 15.0 20/93 17.7 28/85 24.8
Ethnicity
White British 24/578 4.0 82/520 13.6 95/507 15.8 141/461 23.4
Pakistani 73/689 9.6 134/628 17.6 164/598 21.5 175/587 23.0
Others 16/216 6.9 36/196 15.5 41/191 17.7 53/179 22.8
Gender
Male 70/708 9.0 159/619 20.4 185/593 23.8 212/566 27.2
Female 43/777 5.2 93/727 11.3 115/705 14.0 157/663 19.1
Maternal smoking
No 90/1051 7.9 177/964 15.5 213/928 18.7 256/885 22.4
Yes 23/433 5.0 74/382 16.2 86/370 18.9 112/344 24.6
Parity
Primiparous 41/571 6.7 87/525 14.2 106/506 17.3 144/468 23.5
Multiparous 70/892 7.3 163/799 16.9 191/771 19.9 218/744 22.7
IMD 2010 quintile score
1 83/998 7.7 183/898 16.9 217/864 20.1 255/826 23.6
2 19/271 6.6 37/253 12.8 45/ 245 15.5 64/226 22.1
3 10/158 6.0 23/ 145 13.7 28/140 16.7 36/132 21.4
4 1/34 2.9 3/32 8.6 4/31 11.4 6/ 29 17.1
5 0/24 0 6/18 25.0 6/18 25.0 8/16 33.3
IMD, index of multiple deprivation.
Table 5 Adjusted and unadjusted RRs and 95% CI for growth patterns and wheezing disorders in the BiB1000 cohort
Unadjusted RR (95% CI; p Value) Adjusted RR (95% CI; p Value)
Age-based weight SDS
Class 2 (fast growth)
Asthma diagnosis 0.82 (0.12 to 5.56; 0.84) 0.81 (0.12 to 5.46; 0.83)
Wheezing symptom 1.50 (0.62 to 3.56; 0.36) 1.59 (0.68 to 3.71; 0.29)
Wheezing disorder diagnosis 1.25 (0.53 to 2.97; 0.61) 1.30 (0.56 to 3.06; 0.54)
Wheezing disorder treatment 0.76 (0.27 to 2.14; 0.60) 0.77 (0.28 to 2.17; 0.63)
Class 3 (slow growth)
Asthma diagnosis 1 1
Wheezing symptom 0.80 (0.21 to 2.93; 0.73) 0.72 (0.20 to 2.63; 0.29)
Wheezing disorder diagnosis 0.67 (0.18 to 2.45; 0.54) 0.60 (0.16 to 2.18; 0.44)
Wheezing disorder treatment 0.81 (0.29 to 2.25; 0.68) 0.81 (0.29 to 2.25; 0.69)
Visits-based weight SDS
Class 2 (inconsistent growth)
Asthma diagnosis 1.66 (0.81 to 3.42; 0.17) 1.47 (0.71 to 3.01; 0.30)
Wheezing symptom 1.15 (0.66 to 1.99; 0.62) 1.13 (0.66 to 1.95; 0.65)
Wheezing disorder diagnosis 1.42 (0.92 to 2.19; 0.11) 1.38 (0.90 to 2.12; 0.14)
Wheezing disorder treatment 1.14 (0.74 to 1.76; 0.55) 1.17 (0.76 to 1.81; 0.47)
Both models were adjusted for birth weight, ethnicity, gender, maternal smoking, parity and maternal SES; class 1 was a reference group in
both models.
BiB, Born in Bradford; RR, relative risk; SDS, standardised scores; SES, socioeconomic status.
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The ﬁndings of the effects of growth on wheezing dis-
orders analyses may not be directly comparable with the
previous studies7 11 13 14 16 17 19–23 as they assumed a
homogeneous growth among the respective study popu-
lation and investigated the effect of overall mean change
on wheezing disorders. However, Rzehak et al18 who
used GMM reported HRs of 1.22 (95% CI 1.08 to 1.39)
and 1.43 (95% CI 0.90 to 2.27) for groups of children
exhibited rapid growth only until 2 years and persistent
rapid growth, respectively. The authors’ growth pattern
and risk estimates were similar to our age-based fast
growth group and visits-based inconsistent growth group,
respectively. Another two studies that investigated the
effects of weight status changes at different age points
reported an insigniﬁcant increase in wheezing disorders
risk which are similar to our ‘inconsistent growth’
groups of the ‘visits-based’ growth pattern risk
estimates.12 15
In our previous meta-analyses and systematic reviews,
we found that low birth weight and high body mass index
(BMI) were associated with wheezing disorders.10 43
However, we also acknowledged that it may not be appar-
ent whether high BMI is causing wheezing disorders or
otherwise from the ﬁndings. This is because children
with wheezing disorders may become less active which
can lead to obesity or obese children may experience
wheezing symptoms due to narrowing of airways. In our
growth patterns and wheezing disorders analyses, we
noted that, on average, the children with lower birth-
weight SDS showed signiﬁcant growth changes during the
ﬁrst 6 months and were more likely to have experienced
wheezing disorder conditions (tables 3 and 5). We also
noted that children with the lowest birthweight SDS were
more likely to be obese and to have experienced wheez-
ing disorder conditions (tables 3 and 5). Given that a very
small proportion of wheezing disorders or treatment
cases were identiﬁed in the ﬁrst 3 and 6 months (see
online supplementary table S3), during which changes in
growth occurred, it may strongly suggest that low birth
weight coupled with rapid change in growth during the
ﬁrst 6 months is a risk factor for wheezing disorders. The
temporal relationship between obesity and wheezing dis-
orders in this study remains difﬁcult to disentangle;
however, in a recent Mendelian randomisation study by
Granell et al,44 it has been reported that obesity precedes
childhood wheezing disorders.
Our work has certain weakness, so that the results
need to be interpreted carefully. First, although the
sample size for birth weight and wheezing disorders was
sufﬁciently large, study participants were those who were
born at a single centre: the Bradford Royal Inﬁrmary
(BRI) maternity hospital. Births in the regional tertiary
centre, home births and births in smaller hospitals
outside Bradford would have been excluded. Second,
participation in the subcohort (BiB1000) of growth pat-
terns was mainly driven by the mothers’ willingness to
participate, and so there is likely to be selection bias.
Third, some of the classes identiﬁed by our GMM
contained a small proportion of children that resulted
in having less precise risk estimates. Fourth, missing
levels of growth data at some ages and visits was substan-
tial, although we applied missing data handling techni-
ques to address this limitation. Fifth, information on
family asthma and breast feeding was missing, so our
models were not adjusted for these potential confound-
ing variables. However, the lack of adjustment may not
have had a drastic effect on our birthweight risk esti-
mates as there was no difference between the studies
that adjusted for family asthma and those did not.10
Likewise, Rzehak et al18 also reported that there was no
signiﬁcant difference between unadjusted and adjusted
(ie, for breast feeding and family asthma) model results.
Nonetheless, there are particular strengths of our ana-
lysis. First, in our birthweight and wheezing disorders
analyses, our sample size was reasonably large. Second,
we were able to implement techniques to reduce poten-
tial bias due to confounding variables such as the use of
DAGs to inform the modelling process. Third, we were
able to implement missing data techniques to minimise
bias and presented both the complete cases and
imputed data sets results to give more insight. Fourth,
although we had small size for growth pattern analysis,
we are able to implement advanced statistical techniques
to account for potential heterogeneity of growth
between and within groups. Finally, we were also able to
use age-speciﬁc and sex-speciﬁc standardised weight
scores which have the advantage of clearly depicting the
growth patterns of children in comparison to the stand-
ard growth reference.34 The standard scores are convert-
ible to percentiles35 which can then be compared with
the growth charts used by clinicians or growth monitor-
ing workers in their daily practice.
In conclusion, in this large prospective cohort data
analysis, we have conﬁrmed that low birthweight chil-
dren have a moderate associated risk of wheezing disor-
ders whereas high birthweight children have a
non-signiﬁcant reduced risk. There is a weak evidence
that suggests ‘fast’ or ‘inconsistent’ growth predispose to
wheezing disorders, and ‘slow’ growth reduces the risk
which needs further investigation using larger data sets.
However, the results may indicate that maintaining
optimal prenatal and postnatal growths reduce a risk of
childhood wheezing disorders.
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